Full text of BACE : Lead Target for Orchestrated Therapy of Alzheimer's Disease
(2010) Varghese, John is part of Wiley Online Library.
BACE (β-site of APP cleaving enzyme) is a critical component in Alzheimer's Disease (AD), and the development of BACE inhibitors shows great potential as a therapy for the disease. BACE: Lead Target for Orchestrated Therapy of Alzheimer's Disease covers virtually all aspects of BACE from initial identification, discovery of inhibitors, and challenges in clinical development, while providing a global understanding essential for productive and successful drug discovery.
For USC users only. Requires USC network connection.
